| Joseph Robert Hartman, MD | |
|
4525 3rd Ave Se, Suite 100, Lacey, WA 98503-1010 | |
| (360) 412-8960 | |
| (360) 412-8970 |
| Full Name | Joseph Robert Hartman |
|---|---|
| Gender | Male |
| Speciality | Radiology - Radiation Oncology |
| Location | 4525 3rd Ave Se, Lacey, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417934985 | NPI | - | NPPES |
| 8129330 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | MD00026465 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Robert Hartman, MD 4525 3rd Ave Se, Suite 100, Lacey, WA 98503-1010 Ph: (360) 412-8960 | Joseph Robert Hartman, MD 4525 3rd Ave Se, Suite 100, Lacey, WA 98503-1010 Ph: (360) 412-8960 |
News Archive
New research suggests that the identification and examination of key cell signaling events required for initiation and progression of cancer might be best accomplished at the single cell level. The research, published by Cell Press in the October issue of the journal Cancer Cell, provides new insight that may lead to better diagnosis and treatment of some complex cancers.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
A draft communique scheduled to be issued at the Group of Eight industrialized nations summit in July in Hokkaido, Japan, does not cite 2010 targets for universal access to HIV/AIDS prevention, care and treatment or for $25 billion in annual aid to Africa that were set at the 2005 G8 summit in Gleneagles, Scotland, the Financial Times reports.
Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth of blood vessels controls tumors development. The blood vessel growth is controlled by several signalling molecules. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Justus Liebig University Giessen have discovered a molecule that plays a key role in this process. They succeeded in reducing tumour growth in their experiments by blocking the phosphodiesterase PDE4.
› Verified 9 days ago
Justin William Suszko, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4525 3rd Ave Se Ste 100, Lacey, WA 98503 Phone: 360-412-8960 Fax: 360-412-8970 | |
Michael Connor, MD Radiology Medicare: Medicare Enrolled Practice Location: 4525 3rd Ave Se # 100, Lacey, WA 98503 Phone: 360-412-8960 | |
Haleigh Ann Werner, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4525 3rd Ave Se, Suite 100, Lacey, WA 98503 Phone: 360-412-8960 Fax: 360-412-8970 | |
Gregory W Allen, M.D., PHD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4525 3rd Ave Se, Suite 100, Lacey, WA 98503 Phone: 360-412-8960 Fax: 360-412-8970 | |
James F Raymond, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4525 3rd Ave Se, Suite 100, Lacey, WA 98503 Phone: 360-412-8960 Fax: 360-412-8970 |